Assenagon Asset Management
ASMB icon

Assenagon Asset Management’s Assembly Biosciences ASMB Stock Holding History

Assenagon Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21,149
Closed -$416K – 1357
2022
Q3 		$416K Sell
21,149
-35,922
-63% -$869K ﹤0.01% 1134
2022
Q2 		$1.44M Buy
57,071
+53,322
+1,422% +$1.23M 0.01% 961
2022
Q1 		$93K Buy
+3,749
New +$80.5K ﹤0.01% 1380
2019
Q4 		– Sell
-4,441
Closed -$524K – 759
2019
Q3 		$524K Sell
4,441
-3,661
-45% -$554K ﹤0.01% 696
2019
Q2 		$1.31M Buy
+8,102
New +$1.54M 0.01% 648

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Assenagon Asset Management's ASMB Position: Q4 2022 in Review

Assenagon Asset Management sold out of Assembly Biosciences (ASMB) in Q4 2022, closing a stake of 21,149 shares — an estimated $416K sold.

Assenagon Asset Management first reported a position in ASMB in Q2 2019 and held it in 5 quarters. The position peaked at $1.44M in Q2 2022. 39 funds tracked by Wall St. Rank hold ASMB as of Q4 2022.

  • Assenagon Asset Management reported no remaining Assembly Biosciences position as of Q4 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 21,149 Assembly Biosciences shares in Q4 2022, an estimated $416K.
  • Assenagon Asset Management first reported a position in Assembly Biosciences in Q2 2019 and held it in 5 quarters.
  • Assenagon Asset Management's Assembly Biosciences position peaked at $1.44M in Q2 2022.
  • 39 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2022.

Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.